Febuxostat API
| Name of Product | Febuxostat API |
|---|---|
| CAS No | 144060‑53‑7 |
| Therapeutic use:- | Xanthine oxidase inhibitor – gout therapy |
| Form:- | API Powder |
| Grade | IH |
| Status | Regular |
Product Overview
Febuxostat API (CAS No. 144060-53-7) is a non-purine selective xanthine oxidase inhibitor.
The product main use has been seen towards the managing of chronic hyperuricemia in patients with gout.
When compared to traditional therapies like Allopurinol, febuxostat does offer a highly specific mechanism of action with improved efficacy and reduced cross-reactivity.
This makes it suitable for patients who are intolerant to Allopurinol.
Therapeutic Applications
Management of gout as it reduces serum uric acid level by the inhibition of xanthine oxidase.
Tends to control Hyperuricemia and benefit for patients with impaired kidney function.
One of the alternatives for Allopurinol is useful for patients who are allergic or intolerant to purine-based treatments.
Off-label use for cardiovascular and renal protective studies is being conducted.
Specification Parameters
Packaging & Storage
It should be stored in HDPE drums, fiber drums, or aluminium foil bags.
Storage has to be done in a tightly sealed container.
The proper shelf life is 24–36 months.
Why Choose Us
We manufacture products under strict quality control with HPLC-verified purity ≥99%.
Produced under GMP-approved facilities.
We do offer reliable distribution channels ensuring timely delivery worldwide.
Flexible options to meet different clients’ requirements.